A GLP-1/apelin dual receptor agonist shows neuroprotective effects in the MPTP mouse model of Parkinson's disease.

Xu A, Wei Y, Liu E, Tong W, Lu A, Zhang F, Flatt P, Gault V, Irwin N, Hölscher C, Zhang Z

Open source

DOI
10.1016/j.bcp.2026.118534
Published
2026 Oct 10
Container
Biochemical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bcp.2026.118534,
  title = {A GLP-1/apelin dual receptor agonist shows neuroprotective effects in the MPTP mouse model of Parkinson's disease.},
  author = {Xu A and Wei Y and Liu E and Tong W and Lu A and Zhang F and Flatt P and Gault V and Irwin N and Hölscher C and Zhang Z},
  year = {2026},
  journal = {Biochemical pharmacology},
  doi = {10.1016/j.bcp.2026.118534},
  url = {https://doi.org/10.1016/j.bcp.2026.118534}
}

RIS

TY  - JOUR
TI  - A GLP-1/apelin dual receptor agonist shows neuroprotective effects in the MPTP mouse model of Parkinson's disease.
AU  - Xu A
AU  - Wei Y
AU  - Liu E
AU  - Tong W
AU  - Lu A
AU  - Zhang F
AU  - Flatt P
AU  - Gault V
AU  - Irwin N
AU  - Hölscher C
AU  - Zhang Z
PY  - 2026
JO  - Biochemical pharmacology
DO  - 10.1016/j.bcp.2026.118534
UR  - https://doi.org/10.1016/j.bcp.2026.118534
ER  - 

APA

A, X., Y, W., E, L., W, T., A, L., F, Z., P, F., V, G., N, I., C, H., & Z, Z. (2026). A GLP-1/apelin dual receptor agonist shows neuroprotective effects in the MPTP mouse model of Parkinson's disease.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2026.118534

Source records